00:00So, when regulatory body is there, it is a regulatory body, it is a regulatory body, it is a regulatory
00:06body, it is easy to do in market,
00:08a proper clinical test, a clear and scale. Where do you get the market?
00:13In clinical trials, there is no market in the market. But in certain years, they will do a retest.
00:21They will do a trial, they will do a combination use.
00:26They will do a trial for that combination. For example, if they are in a product, they will do a
00:33trial for that.
00:34They will do a trial for that combination, they will do a data. For example, inpatient study trial, they will
00:43do a budget for that.
00:46So, in this way, they will follow strict regulations.
00:49They will do a follow-up model. But in this way, DCGI is strict and stringent. Everything is digitalized.
00:57They have to be digitalized.
00:58They have to be done with the files, they have to be done with officers.
01:02So, it has become at least 70-80% digitalized.
01:04So, it will do a trial for these cases.
01:05You know, the website, this has become a small player.
01:06It is a much more complete study.
Comments